Editor

Differentiation between benign and malignant processes is helped by positron emission tomography -- computed tomography (PET-CT). This involves a scan one hour after intravenous injection of Fluorodeoxyglucose (FDG) tracer.[@b1] Malignant lesions use glucose preferentially, with prolonged affinity for FDG, thus appearing as a "hot spot" as quantified by elevated maximum standarised uptake value (SUVmax). Infective processes also induce increased FDG uptake.[@b2] Dualphase scanning, which employs both early and delayed scans may separate these conditions. We report two cases where dual-phase scanning resulted in a change in the patients\' diagnosis and management.

CASES
=====

A 55-year-old male life-long smoker presented with chest pain, shortness of breath and haemoptysis. A CT scan demonstrated an obstructing lesion in the left lower lobe bronchus and distal consolidation. Bronchoscopic biopsies were reported as squamous cell carcinoma. A ^18^F-FDG PET/CT half-body one-hour and four-hour washout studies were performed ([Figure 1](#fig01){ref-type="fig"}). An abnormality in the proximal left main bronchus had a SUVmax value of 13.9, with distal atelectasis and central necrosis. However, FDG uptake was seen anterolaterally within the collapsed segment, with a SUVmax of 10. Delayed imaging showed a 20% increased SUVmax of the central hilar and anterolateral peripheral lesions, with the necrotic area showing no change in SUVmax ([Figure 2](#fig02){ref-type="fig"}). The findings were inkeeping with hilar and peripheral malignant lesions, with surrounding inflammation. Histopathology confirmed a pT4 N1 squamous cell carcinoma, with satellite lesions and aspergillus infection in the collapsed lower lobe. Unfortunately, he developed local recurrence and bony metastases and died seven months following resection.
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A 46-year-old female smoker presented with shortness of breath and a productive cough. CT demonstrated right upper lobe collapse and a central lesion. Bronchoscopy visualised a friable necrotic lesion obstructing the right upper lobe provisionally diagnosed as malignancy. Cytology was atypical, with a small piece of vegetable matter, suggesting aspiration. ^18^F-FDG PET/CT showed a lesion, with a SUVmax of 5.6, in the right upper lobe bronchus, suggesting a hilar tumour and distal atelectasis with SUVmax of 4.8 ([Figure 3](#fig03){ref-type="fig"}). A washout study revealed a decreased SUVmax from 5.6 to 3.4 in the hilar lesion, inkeeping with inflammation ([Figure 4](#fig04){ref-type="fig"}). Repeat bronchoscopy retrieved vegetable matter with no histological malignancy.
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DISCUSSION
==========

Malignant cells have upregulated GLUT transporter and hexokinase activity, trapping FDG.[@b1], [@b3] After phosphorylation by hexokinase, FDG-6-phosphate cannot be used nor stored.[@b1], [@b3] FDG uptake in malignant cells continues and SUVmax peaks 130-500 minutes after FDG injection.[@b4] Inflamed tissue, with higher metabolic rate will also light up. However, FDG will be metabolised and replaced by unlabelled glucose. If a malignant cell is present, the continued FDG uptake between scans results in higher intensity of retained FDG at 4 hours. Inflammatory cells, which retain normal glucose-6-phosphatase activity, will have decreased signal. In our experience, a rise in SUVmean of 30% correlates with malignant disease, with no increase suggesting benign diagnosis.[@b5] In the presence of infection satellite lesions may be missed, thus understaging the disease, with possible unnecessary non-curative surgery. Despite additional cost, a washout study can alter the management strategy of patients.

The authors have no conflict of interest.
